Mycenax Biotech Inc. (TPEX:4726)

Mycenax Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	9,370	7,350	7,699	5,811	4,129	2,981
Market Cap Growth	30.74%	-4.53%	32.48%	40.74%	38.50%	5.09%
Enterprise Value	9,883	7,281	8,353	5,998	3,966	2,671
Last Close Price	45.35	35.70	37.50	37.90	32.20	23.30
PE Ratio	-	-	-	-	133.43	-
PS Ratio	13.87	11.26	10.51	7.51	6.21	7.63
PB Ratio	4.47	3.00	2.48	3.05	3.41	2.71
P/TBV Ratio	4.97	3.06	2.52	3.14	3.59	2.90
P/OCF Ratio	-	-	-	-	23.71	-
EV/Sales Ratio	14.69	11.16	11.41	7.75	5.96	6.83
EV/EBITDA Ratio	-	-	-	135.31	26.30	-
EV/EBIT Ratio	-	-	-	-	112.05	-
Debt / Equity Ratio	0.44	0.30	0.31	0.39	0.16	0.04
Debt / EBITDA Ratio	-	-	-	9.96	1.15	-
Asset Turnover	0.18	0.16	0.19	0.32	0.42	0.31
Inventory Turnover	9.19	5.73	4.03	4.93	6.79	4.43
Quick Ratio	0.78	0.97	2.24	1.15	1.10	1.75
Current Ratio	1.29	1.46	3.03	1.66	1.36	2.13
Return on Equity (ROE)	-22.84%	-24.59%	-18.10%	-5.76%	2.68%	-21.72%
Return on Assets (ROA)	-8.42%	-9.15%	-7.33%	-2.18%	1.40%	-11.39%
Return on Capital (ROIC)	-9.66%	-10.40%	-8.29%	-2.63%	1.73%	-14.00%
Return on Capital Employed (ROCE)	-	-	-	-	2.67%	-
Earnings Yield	-5.72%	-9.29%	-5.89%	-1.55%	0.75%	-7.32%
FCF Yield	-5.83%	-5.81%	-10.09%	-21.41%	-2.08%	-10.69%
Buyback Yield / Dilution	-0.99%	-24.31%	-11.35%	-15.36%	-2.37%	-14.36%
Total Shareholder Return	-0.99%	-24.31%	-11.35%	-15.36%	-2.37%	-14.36%

Source: S&P Capital IQ. Standard template. Financial Sources.